Amneal Pharmaceuticals will pay more than $270 million to resolve claims it helped fuel the opioid epidemic, becoming the latest drug company to settle lawsuits over the addiction crisis.
The proposal must be reviewed by the White House OMB, and then undergo a public-comment period and review from an administrative judge, a potentially lengthy process.